GOLGI ALPHA-MANNOSIDASE II complex with (2R,3R,4S)-2-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidine-3,4-diol

GOLGI ALPHA-MANNOSIDASE II complex with (2R,3R,4S)-2-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidine-3,4-diol Descriptor: (2R,3R,4S)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL, (4S)-2-METHYL-2,4-PENTANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... Authors: Kuntz, D.A, Rose, D.R. Deposit date: 2005-11-14 Release date: 2006-12-05 Last modified: 2024-11-13 Method: X-RAY DIFFRACTION (1.3 Å) Cite: Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography. Proteins, 69, 2007

高尔基α-甘露糖苷酶II与(2R,3R,4S)-2-{[(1R)-2-羟基-1-苯乙基]氨基}甲基吡咯烷-3,4-二醇复合物。描述项：(2R,3R,4S)-2-{[(1R)-2-羟基-1-苯乙基]氨基}甲基吡咯烷-3,4-二醇、(4S)-2-甲基-2,4-戊二醇、2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖，……。作者：Kuntz D.A.、Rose D.R.。提交日期：2005-11-14。发布日期：2006-12-05。最后修改日期：2024-11-13。实验方法：X射线衍射（1.3埃）。引用文献：《用于预测高尔基α-甘露糖苷酶II抑制剂结合能力的对接程序评估：与晶体学方法的对比》，《Proteins》，第69卷，2007年。